Precision Medicine in Pediatric Cancer: Current Applications and Future Prospects
Open Access
Abstract
Precision oncologic medicine is an emerging approach for cancer treatment that has recently taken giant steps in solid clinical practice. Recent advances in molecular diagnostics that can analyze the individual tumor’s variability in genes have provided greater understanding and additional strategies to treat cancers. Although tumors can be tested by several molecular methods, the use of next-generation sequencing (NGS) has greatly facilitated our understanding of pediatric cancer and identified additional therapeutic opportunities. Pediatric tumors have a different genetic make-up, with a fewer number of actionable targets than adult tumors. Nevertheless, precision oncology in the pediatric population has greatly improved the survival of patients with leukemia and solid tumors. This review discusses the current status of pediatric precision oncology and the different clinical scenarios in which it can be effectively applied.Keywords
This publication has 47 references indexed in Scilit:
- Engineering CAR-T cells: Design conceptsTrends in Immunology, 2015
- Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment ResponseJAMA Oncology, 2015
- On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 PatientsMolecular Cancer Therapeutics, 2015
- Epigenetic regulators as promising therapeutic targets in acute myeloid leukemiaTherapeutic Advances in Hematology, 2015
- Ten years of next-generation sequencing technologyTrends in Genetics, 2014
- Clinical Integration of Next Generation Sequencing: Coverage and Reimbursement ChallengesJournal of Law, Medicine & Ethics, 2014
- Precision Oncology: An OverviewJournal of Clinical Oncology, 2013
- Personalizing Oncology: Perspectives and ProspectsJournal of Clinical Oncology, 2013
- Personalized oncology: Recent advances and future challengesMetabolism, 2013
- Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistanceDrug Resistance Updates, 2011